Georg Schett

Georg Schett's research focuses on understanding and treating autoimmune diseases, with the goal of moving from lifelong immunosuppression toward curative therapies. He pioneered the use of CD19 CAR T cells in severe autoimmune diseases, demonstrating that deep depletion of disease-causing immune cells can reset the immune system and enable sustained, drug-free remission. His work advances cell-based therapies as a new treatment paradigm for autoimmune diseases.